Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Haemonetics (HAE) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to $15.2 million.

  • Haemonetics' Tax Provisions rose 2263.54% to $15.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $51.7 million, marking a year-over-year increase of 4922.99%. This contributed to the annual value of $44.4 million for FY2025, which is 2941.97% up from last year.
  • Haemonetics' Tax Provisions amounted to $15.2 million in Q4 2025, which was up 2263.54% from $12.6 million recorded in Q3 2025.
  • Haemonetics' 5-year Tax Provisions high stood at $15.2 million for Q4 2025, and its period low was -$16.4 million during Q2 2021.
  • For the 5-year period, Haemonetics' Tax Provisions averaged around $7.4 million, with its median value being $8.3 million (2022).
  • As far as peak fluctuations go, Haemonetics' Tax Provisions plummeted by 47808.6% in 2021, and later skyrocketed by 32447.62% in 2025.
  • Quarter analysis of 5 years shows Haemonetics' Tax Provisions stood at $5.1 million in 2021, then soared by 82.35% to $9.3 million in 2022, then skyrocketed by 37.63% to $12.8 million in 2023, then decreased by 2.95% to $12.4 million in 2024, then rose by 22.64% to $15.2 million in 2025.
  • Its last three reported values are $15.2 million in Q4 2025, $12.6 million for Q3 2025, and $11.1 million during Q2 2025.